Search from the table of contents of 2.5 million books
Advanced Search (Beta)
Home > Cardiac Arrhythmias: New Therapeutic Drugs and Devices: Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA October 4 and 5, 1984 > How to Test for Antiarrhythmic Drugs
Cardiac Arrhythmias: New Therapeutic Drugs and Devices: Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA October 4 and 5, 1984 |
J. Morganroth; E. Neil Moore
Springer US
Cardiac Arrhythmias: New Therapeutic Drugs and Devices: Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA October 4 and 5, 1984
How to Test for Antiarrhythmic Drugs
Authors

Brian F. Hoffman

ARI Id

1664657598775_2597488

Access

Not Available Free

Pages

12-21

DOI

10.1007/978-1-4613-2595-6_2

Chapter URL

https://rd.springer.com/chapter/10.1007/978-1-4613-2595-6_2

Table of Contents of Book
Showing 1 to 20 of 34 entries
Chapters/HeadingsAuthor(s)PagesInfo
Front Matter
i-xii
Front Matter
1-1
What Animal Models are Useful in Selecting New Antiarrhythmic Drugs?
E. Neil Moore; Joseph F. Spear
3-11
How to Test for Antiarrhythmic Drugs
Brian F. Hoffman
12-21
Initial Evaluation of New Antiarrhythmic Agents in Man: Normal Volunteers or Patients?
Raymond L. Woosley; John A. Oates
22-35
Is There a Rational Basis for the Modified Classification of Antiarrhythmic Drugs?
Donald C. Harrison
36-40
Back Matter
41-47
Front Matter
49-49
Procainamide, Quinidine, Disopyramide, Cibenzoline, Pirmenol — Efficacy in the Treatment of Ventricular Arrhythmias: Current Status and Controversies
Craig M. Pratt
51-67
Mexiletine, Tocainide and Ethmozine: Newer Class I Antiarryhthmic Agents
Allan M. Greenspan
68-97
Class IC Antiarrhythmic Agents: Status — 1984
Joel Morganroth
98-131
Role of Beta-Blocking Agents in the Treatment of Ventricular Arrhythmias
Joel Morganroth
132-142
Status of Class III Antiarrhythmic Drugs: Amiodarone, Bretylium and Sotalol
Leonard N. Horowitz
143-166
Back Matter
167-177
Front Matter
179-179
Some Thoughts on Efficacy Trials of Antiarrhythmic Agents: Pitfalls of Mimicking Clinical Practice
Gordon Pledger
181-183
Use of a Computer in the New Drug Evaluation Process
Stewart J. Ehrreich
184-190
Sudden Cardiac Death — Failure or Effect of Antiarrhythmic Drug Therapy?
Ronald W. F. Campbell
191-200
Sudden Death as an End-Point for the Clinical Evaluation of Antiarrhythmic Drugs
Jay N. Cohn; Thomas Rector
201-210
Holter/Exercise and Electrophysiologic Methods for Evaluating Drug Therapy for Malignant Ventricular Arrhythmias: Do We Need Both Models?
J. Thomas Bigger Jr.
211-221
Chapters/HeadingsAuthor(s)PagesInfo
Showing 1 to 20 of 34 entries
Similar Books
Similar Chapters
Similar Thesis

Similar News

Similar Articles
Similar Article Headings